McKesson 2015 Annual Report Download - page 8

Download and view the complete annual report

Please find page 8 of the 2015 McKesson annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 146

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146

McKESSON CORPORATION
PART I
Item 1. Business.
General
McKesson Corporation (“McKesson,” the “Company,” the “Registrant” or “we” and other similar
pronouns), currently ranked 15th on the Fortune 500, delivers pharmaceuticals, medical supplies and healthcare
information technology that make healthcare safer while reducing costs.
The Company’s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references
in this document to a particular year shall mean the Company’s fiscal year.
Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and
amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act
of 1934, as amended (the “Exchange Act,”) are available free of charge on our website (www.mckesson.com
under the “Investors — Financial Information — SEC Filings” caption) as soon as reasonably practicable after
we electronically file such material with, or furnish it to, the Securities and Exchange Commission (“SEC” or the
“Commission”). The content on any website referred to in this Annual Report on Form 10-K is not incorporated
by reference into this report, unless expressly noted otherwise.
The public may also read or copy any materials that we file with the SEC at the SEC’s Public Reference
Room at 100 F Street, N.E., Washington, DC 20549. The public may obtain information on the operation of the
Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains a website that contains
reports, proxy and information statements, and other information regarding issuers, including the Company, that
file electronically with the SEC. The address of the website is www.sec.gov.
Business Segments
We operate in two segments. The McKesson Distribution Solutions segment distributes ethical and proprietary
drugs and equipment and health and beauty care products throughout North America and internationally. This
segment includes our International pharmaceutical distribution and services business which reflects the results of
operations of Celesio AG (“Celesio”), which we acquired in February 2014. Celesio supplies pharmaceuticals and
other healthcare-related products through its pharmaceutical wholesale business and retail pharmacies.
The Distribution Solutions segment provides specialty pharmaceutical solutions for biotech and
pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to
oncology and other specialty practices operating in the community setting. It also provides medical-surgical
supply distribution, equipment, logistics and other services to healthcare providers through a network of
distribution centers within the U.S. In addition, this segment sells financial, operational and clinical solutions for
pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing and other services.
The Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply chain
and strategic management software solutions, as well as connectivity, outsourcing and other services, including
remote hosting and managed services, to healthcare organizations.
Net revenues for our segments for the last three years were as follows:
Years Ended March 31,
(Dollars in billions) 2015 2014 2013
Distribution Solutions $176.0 98% $134.1 98% $119.0 97%
Technology Solutions 3.1 2 3.3 2 3.2 3
Total $179.1 100% $137.4 100% $122.2 100%
3